Prognostic factors in myelodysplastic syndromes.

[1]  D. Bowen,et al.  Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome , 1990, British journal of haematology.

[2]  S. Larsen,et al.  Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. , 1990, Blood.

[3]  M. Sanz,et al.  Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors , 1990, British journal of haematology.

[4]  X. Thomas,et al.  Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns , 1990, American journal of hematology.

[5]  P. Hokland,et al.  Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes , 1990, British journal of haematology.

[6]  N. Gattermann,et al.  Two types of acquired idiopathic sideroblastic anaemia (AISA) , 1990, British journal of haematology.

[7]  J. Goasguen,et al.  Prognostic factors of myelodysplastic syndromes--a simplified 3-D scoring system. , 1990, Leukemia research.

[8]  A. Audebert,et al.  Refractory anemia with excess of blasts in transformation. Clinical, hematologic, and cytogenetic findings in nine patients. , 1989, Cancer genetics and cytogenetics.

[9]  M. Sanz,et al.  Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. , 1989, Blood.

[10]  E. Montserrat,et al.  Acute transformation of chronic myelomonocytic leukaemia: a multivariate study of predictive factors , 1989, European journal of haematology.

[11]  D. Oscier,et al.  Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score. , 1989, Leukemia research.

[12]  M. Bar‐eli,et al.  Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. , 1989, Blood.

[13]  F. Mitelman,et al.  Bone marrow karyotype and prognosis in primary myelodysplastic syndromes , 1988, European journal of haematology.

[14]  M. Taniwaki,et al.  Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis , 1988, Cancer.

[15]  R. Beuscart,et al.  Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  F. McCormick,et al.  RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. , 1988, Leukemia.

[17]  J. Nauta,et al.  Myelodysplastic syndromes: Analysis of clinical and prognostic features in 96 patients , 1988, European journal of haematology.

[18]  G. Mufti,et al.  Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. , 1988, Blood.

[19]  R. Beuscart,et al.  Refractory anaemia according to the FAB classification: A report on 69 cases , 1988, European journal of haematology.

[20]  J. I. Lorenzo,et al.  Prognostic factors in chronic myelodysplastic syndromes: A multivariate analysis in 107 cases , 1988, American journal of hematology.

[21]  M. Cazzola,et al.  Natural history of idiopathic refractory sideroblastic anemia , 1988 .

[22]  M. Cazzola,et al.  Prognostic parameters in myelodysplastic syndromes: A multiple regression analysis , 1988, European journal of haematology.

[23]  M. Oken,et al.  Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia , 1988, British journal of haematology.

[24]  G. Mufti,et al.  Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival , 1988, British journal of haematology.

[25]  J. Ribera,et al.  A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria , 1987, British journal of haematology.

[26]  J. Hermans,et al.  Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases , 1987, British journal of haematology.

[27]  D. Galton.  The myelodysplastic syndromes. Part I. What are they? Part II. Classification. , 2009, Scandinavian journal of haematology. Supplementum.

[28]  G. Tricot,et al.  Prognostic factors in the myelodysplastic syndromes: a review. , 2009, Scandinavian journal of haematology. Supplementum.

[29]  E. Polli,et al.  Inhibition of proliferation of human leukaemic cell populations by deferoxamine. , 2009, Scandinavian journal of haematology.

[30]  Greenberg Pl.  In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. , 1986 .

[31]  R. Clark,et al.  Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes. , 1986, The New England journal of medicine.

[32]  J. Rowley,et al.  Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes , 1986 .

[33]  M. Oken,et al.  Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. , 1986, Blood.

[34]  A. Julià,et al.  Myelodysplastic syndromes: a study of 101 cases according to the FAB classification , 1985, British journal of haematology.

[35]  R. H. Knapp,et al.  Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. , 1985, Mayo Clinic proceedings.

[36]  G. Tricot,et al.  The 5q-anomaly. , 1985, Cancer genetics and cytogenetics.

[37]  G. Tricot,et al.  Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis , 1985, British journal of haematology.

[38]  G. Tricot,et al.  The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations , 1985, British journal of haematology.

[39]  H. Heimpel,et al.  Karyotypic evolution in patients with myelodysplastic syndromes. , 1985, Cancer genetics and cytogenetics.

[40]  D. Machin,et al.  Myelodysplastic syndromes: a scoring system with prognostic significance , 1985, British journal of haematology.

[41]  A. Williams,et al.  The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification , 1985, British journal of haematology.

[42]  J. Bennett,et al.  Modifications in the classification of primary myelodysplastic syndromes: The addition of a scoring system , 1985, Hematological oncology.

[43]  D. Galton.  The myelodysplastic syndromes. , 1987, Clinical and laboratory haematology.

[44]  M. Oken,et al.  Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia , 1983, British journal of haematology.

[45]  F. Sigaux,et al.  Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases. , 1983, Journal of clinical pathology.

[46]  G. Mazzini,et al.  Proliferative activity of bone marrow cells in primary dysmyelopoietic (preleukemic) syndromes , 1983, Cancer.

[47]  P. Greenberg.  The smoldering myeloid leukemic states: clinical and biologic features. , 1983, Blood.

[48]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[49]  P. Nowell.  Cytogenetics of preleukemia. , 1982, Cancer genetics and cytogenetics.

[50]  C. Berzuini,et al.  Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes , 1982, British journal of haematology.

[51]  R. L. Anderson,et al.  The prognostic value of chromosome studies in patients with the preleukemic syndrome (hemopoietic dysplasia). , 1982, Leukemia research.

[52]  D. Seigneurin,et al.  Use of the tritiated thymidine-labelling index of the myeloblast-promyelocyte pool for the identification of the leukemic population in oligoblastic leukemia. , 1981, Acta haematologica.

[53]  A. Sandberg.  Second International Workshop on Chromosomes in Leukemia. , 1980, Cancer research.

[54]  G. Spitzer,et al.  In vitro agar culture patterns in preleukemia and their clinical significance. , 1979, Leukemia research.